Intellectual Property Committee

The IGBA Intellectual Property Committee promotes the implementation of balanced, well-functioning and transparent intellectual property systems in all jurisdictions. This objective aims to bring competition to markets at the earliest appropriate opportunity, and provides patients with timely access to cost-saving generic and biosimilar medicines. This objective also supports the sustainability and future growth of investments made by the industry in new product development, manufacturing and the litigation that is generally required to bring new generic pharmaceuticals and biosimilar medicines to domestic markets. 

Contact Info


Rue d'Arlon, 50
B-1000 Brussels, Belgium

Telephone: +32 (0)2 736 84 11
Fax: +32 (0)2 736 74 38
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete them, see our Privacy Policy.

I accept cookies from this site